|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||46.85 - 47.40|
|52 Week Range||39.72 - 48.38|
|Beta (5Y Monthly)||0.27|
|PE Ratio (TTM)||20.48|
|Forward Dividend & Yield||1.22 (2.55%)|
|Ex-Dividend Date||Mar 18, 2021|
|1y Target Est||N/A|
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the cobas® SARS-CoV-2 Nucleic acid test for use on the cobas® Liat® System. This singleplex test is the first real-time reverse transcriptase polymerase chain reaction (RT-PCR) test that can identify SARS-CoV-2 infection within 20 minutes.
In this episode of Influencers, Eli Lilly Chairman & CEO David Ricks joins Andy to discuss the latest in the pharmaceutical industry, new progress in the fight against COVID-19, and potential groundbreaking advancements for the treatment of Alzheimer’s.
Eli Lilly CEO David Ricks joins 'Influencers with Andy Serwer' to discuss progress in the fight against COVID-19.